ImpediMed Ltd
ASX:IPD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ImpediMed Ltd
ASX:IPD
|
AU |
Balance Sheet
Balance Sheet Decomposition
ImpediMed Ltd
ImpediMed Ltd
Balance Sheet
ImpediMed Ltd
| Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
0
|
7
|
4
|
3
|
3
|
5
|
11
|
33
|
82
|
55
|
31
|
11
|
20
|
20
|
41
|
46
|
25
|
22
|
|
| Cash |
0
|
0
|
7
|
4
|
3
|
3
|
5
|
11
|
33
|
3
|
8
|
3
|
3
|
11
|
8
|
9
|
32
|
6
|
1
|
|
| Cash Equivalents |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
80
|
47
|
28
|
8
|
9
|
11
|
31
|
14
|
18
|
22
|
|
| Short-Term Investments |
0
|
8
|
0
|
15
|
15
|
12
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
4
|
4
|
4
|
4
|
5
|
5
|
4
|
4
|
3
|
4
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
|
| Inventory |
0
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
4
|
11
|
8
|
21
|
20
|
17
|
9
|
13
|
35
|
88
|
61
|
38
|
17
|
25
|
26
|
47
|
52
|
29
|
28
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
2
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
2
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
4
|
4
|
|
| Intangible Assets |
0
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
5
|
9
|
12
|
13
|
10
|
|
| Goodwill |
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
2
|
3
|
3
|
3
|
3
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
2
|
3
|
3
|
3
|
3
|
|
| Total Assets |
4
N/A
|
15
+241%
|
13
-10%
|
25
+90%
|
23
-8%
|
20
-14%
|
12
-40%
|
15
+26%
|
38
+153%
|
91
+139%
|
64
-29%
|
42
-35%
|
23
-46%
|
33
+46%
|
34
+3%
|
59
+72%
|
69
+17%
|
47
-32%
|
42
-11%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
2
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
3
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
2
|
6
|
3
|
3
|
2
|
2
|
|
| Short-Term Debt |
21
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Total Current Liabilities |
22
|
2
|
3
|
3
|
2
|
2
|
1
|
1
|
3
|
5
|
5
|
6
|
7
|
5
|
8
|
7
|
6
|
5
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
14
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Liabilities |
22
N/A
|
2
-90%
|
3
+37%
|
3
-12%
|
2
-21%
|
2
+8%
|
1
-45%
|
1
+13%
|
3
+115%
|
5
+73%
|
6
+4%
|
6
+4%
|
7
+18%
|
6
-16%
|
9
+52%
|
8
-12%
|
8
+3%
|
6
-21%
|
21
+239%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
11
|
51
|
61
|
85
|
98
|
106
|
106
|
117
|
147
|
219
|
219
|
220
|
220
|
251
|
267
|
308
|
336
|
336
|
336
|
|
| Retained Earnings |
29
|
39
|
51
|
62
|
77
|
88
|
96
|
103
|
116
|
139
|
164
|
189
|
210
|
229
|
247
|
263
|
283
|
304
|
325
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
3
|
6
|
4
|
5
|
6
|
6
|
5
|
7
|
8
|
8
|
9
|
|
| Total Equity |
18
N/A
|
12
N/A
|
10
-18%
|
22
+121%
|
21
-7%
|
17
-16%
|
11
-39%
|
14
+28%
|
35
+157%
|
85
+145%
|
59
-31%
|
36
-39%
|
16
-56%
|
27
+73%
|
26
-7%
|
51
+100%
|
61
+19%
|
41
-33%
|
20
-50%
|
|
| Total Liabilities & Equity |
4
N/A
|
15
+241%
|
13
-10%
|
25
+90%
|
23
-8%
|
20
-14%
|
12
-40%
|
15
+26%
|
38
+153%
|
91
+139%
|
64
-29%
|
42
-35%
|
23
-46%
|
33
+46%
|
34
+3%
|
59
+72%
|
69
+17%
|
47
-32%
|
42
-11%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
85
|
86
|
101
|
141
|
163
|
188
|
188
|
248
|
307
|
392
|
394
|
397
|
398
|
1 002
|
1 492
|
1 778
|
2 018
|
2 023
|
2 027
|
|